Citation Impact
Citing Papers
X-linked cholestasis in mouse due to mutations of the P4-ATPase ATP11C
2011 StandoutNobel
Strategy for Dual-Analyte Luciferin Imaging: In Vivo Bioluminescence Detection of Hydrogen Peroxide and Caspase Activity in a Murine Model of Acute Inflammation
2013 StandoutNobel
ZBTB1 is a determinant of lymphoid development
2011 StandoutNobel
Riding the tiger – physiological and pathological effects of superoxide and hydrogen peroxide generated in the mitochondrial matrix
2020
Anti-Islet Autoantibodies Trigger Autoimmune Diabetes in the Presence of an Increased Frequency of Islet-Reactive CD4 T Cells
2011
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Ischemia and reperfusion—from mechanism to translation
2011 Standout
Deficiency of eNOS exacerbates early-stage NAFLD pathogenesis by changing the fat distribution
2015
From NASH to HCC: current concepts and future challenges
2019
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
Acute kidney injury
2012 Standout
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
2012
Inflammatory links between obesity and metabolic disease
2011 Standout
Curcumin inhibits NF-κB activation and reduces the severity of experimental steatohepatitis in mice
2004
Reactive oxygen and mechanisms of inflammatory liver injury: Present concepts
2011
Mechanisms of hepatic stellate cell activation
2017 Standout
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Chronic inflammation in the etiology of disease across the life span
2019 Standout
Liver transplantation and non-alcoholic fatty liver disease
2014
Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
2016
The NLRP3 inflammasome: molecular activation and regulation to therapeutics
2019 Standout
Impaired liver regeneration in Nrf2 knockout mice: role of ROS‐mediated insulin/IGF‐1 resistance
2007
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
2017 Standout
The Role of Cholesterol in the Pathogenesis of NASH
2015
Hallmarks of aging: An expanding universe
2023 Standout
A complement-dependent balance between hepatic ischemia/reperfusion injury and liver regeneration in mice
2009
Microglial cell origin and phenotypes in health and disease
2011 Standout
Pattern Recognition Receptors and Inflammation
2010 Standout
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
2018
Hepatocellular carcinoma
2021 Standout
Mechanisms and disease consequences of nonalcoholic fatty liver disease
2021
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Targeting the NLRP3 inflammasome in inflammatory diseases
2018
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
2016
Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders
2020
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Molecular and cellular mechanisms of liver fibrosis and its regression
2020
Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathology
2006 Standout
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Acute kidney injury
2019 Standout
Inhibition of De Novo NAD + Synthesis by Oncogenic URI Causes Liver Tumorigenesis through DNA Damage
2014
Epigenetic Regulation of Kupffer Cell Function in Health and Disease
2021
Non-alcoholic fatty liver disease
2021 Standout
Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors
2020 StandoutNobel
Gasdermin D plays a key role as a pyroptosis executor of non-alcoholic steatohepatitis in humans and mice
2017
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Dynamics and functions of lipid droplets
2018 Standout
SREBP-regulated lipid metabolism: convergent physiology — divergent pathophysiology
2017
A multicomponent toxin from Bacillus cereus incites inflammation and shapes host outcome via the NLRP3 inflammasome
2018
Non-alcoholic fatty liver disease and liver transplantation
2016
Cellular Stresses and Stress Responses in the Pathogenesis of Insulin Resistance
2018
Type 1 diabetes
2013 Standout
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
The P4-type ATPase ATP11C is essential for B lymphopoiesis in adult bone marrow
2011 StandoutNobel
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
2017
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Carbon Monoxide Inhibition of Apoptosis during Ischemia-Reperfusion Lung Injury Is Dependent on the p38 Mitogen-activated Protein Kinase Pathway and Involves Caspase 3
2003
TOLL-LIKE RECEPTORS IN ISCHEMIA-REPERFUSION INJURY
2009
Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis
2016
Lipid somersaults: Uncovering the mechanisms of protein-mediated lipid flipping
2016
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
2016
Past, present and future perspectives in nonalcoholic fatty liver disease
2019
Kupffer cells in non-alcoholic fatty liver disease: The emerging view
2009
NF-κB Activation, Rather Than TNF, Mediates Hepatic Inflammation in a Murine Dietary Model of Steatohepatitis
2005
Inflammasome activation and function in liver disease
2015
Hydrogen sulfide attenuates hepatic ischemia-reperfusion injury: role of antioxidant and antiapoptotic signaling
2008
Inflammation in obesity, diabetes, and related disorders
2022 Standout
Dispensable roles of Gsdmd and Ripk3 in sustaining IL-1β production and chronic inflammation in Th17-mediated autoimmune arthritis
2021 StandoutNobel
FK330, a Novel Inducible Nitric Oxide Synthase Inhibitor, Prevents Ischemia and Reperfusion Injury in Rat Liver Transplantation
2006
Vascular ischaemia and reperfusion injury
2004
Mitochondrial Glutathione, a Key Survival Antioxidant
2009
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Diet and exercise in NAFLD/NASH: Beyond the obvious
2021
Physiological Implications of Hydrogen Sulfide: A Whiff Exploration That Blossomed
2012 Standout
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
2013
Hepatocellular Carcinoma
2019 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation
2019 Standout
Role of Cholesterol‐Associated Steatohepatitis in the Development of NASH
2021
Common Pathological Processes and Transcriptional Pathways in Alzheimer's Disease and Type 2 Diabetes
2009
Nonalcoholic Fatty Liver Disease: Pathogenesis and Disease Spectrum
2016
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
2017 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Inhibition of the NLRP3 inflammasome improves lifespan in animal murine model of Hutchinson–Gilford Progeria
2021
Lipotoxicity and the gut-liver axis in NASH pathogenesis
2017
Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning
2003
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
The KEAP1-NRF2 System: a Thiol-Based Sensor-Effector Apparatus for Maintaining Redox Homeostasis
2018 Standout
Review article: emerging anti‐fibrotic therapies in the treatment of non‐alcoholic steatohepatitis
2016
The independent predictors of non‐alcoholic steatohepatitis and its individual histological features.
2016
The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
2023 Standout
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
2020
Inflammatory Mechanisms in Obesity
2011 Standout
Reactive Oxygen Species in Metabolic and Inflammatory Signaling
2018 Standout
Updates on Hepato-Renal Syndrome
2013
Molecular therapy for hepatic injury and fibrosis: Where are we
2006
Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells
2013 StandoutNobel
A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition
2017
Physical Activity and Low Glycemic Index Mediterranean Diet: Main and Modification Effects on NAFLD Score. Results from a Randomized Clinical Trial
2020
Fast detection of liver fibrosis with collagen-binding single-nanometer iron oxide nanoparticles via T 1 -weighted MRI
2023 StandoutNobel
Works of Narci Teoh being referenced
Mice Deficient in the Putative Phospholipid Flippase ATP11C Exhibit Altered Erythrocyte Shape, Anemia, and Reduced Erythrocyte Life Span*
2014
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
2017
Pharmacological cholesterol lowering reverses fibrotic NASH in obese, diabetic mice with metabolic syndrome
2013
Hepatic ischemic preconditioning in mice is associated with activation of NF-κB, p38 kinase, and cell cycle entry
2002
The damage-associated molecular pattern HMGB1 is released early after clinical hepatic ischemia/reperfusion
2019
ATP11C is critical for the internalization of phosphatidylserine and differentiation of B lymphocytes
2011
Mouse Models of Nonalcoholic Steatohepatitis
2018
Exercise retards hepatocarcinogenesis in obese mice independently of weight control
2020
Defective DNA strand break repair causes chromosomal instability and accelerates liver carcinogenesis in mice
2008
Hepatic ischemia reperfusion injury: Pathogenic mechanisms and basis for hepatoprotection
2003
Cholesterol-lowering drugs cause dissolution of cholesterol crystals and disperse Kupffer cell crown-like structures during resolution of NASH
2014
Roles of adipose restriction and metabolic factors in progression of steatosis to steatohepatitis in obese, diabetic mice
2009
Microparticles Mediate Hepatic Ischemia-Reperfusion Injury and Are the Targets of Diannexin (ASP8597)
2014
Hepatic Free Cholesterol Accumulates in Obese, Diabetic Mice and Causes Nonalcoholic Steatohepatitis
2011
Hepatic Microcirculation in Fatty Liver Disease
2008
Dual role of tumor necrosis factor-α in hepatic ischemia-reperfusion injury: Studies in tumor necrosis factor-α gene knockout mice
2004
Ethanol reduces p38 kinase activation and cyclin D1 protein expression after partial hepatectomy in rats
2005
Testosterone regulation of cyclin E kinase: A key factor in determining gender differences in hepatocarcinogenesis
2015
TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival
2017
Peroxisome proliferator activated receptor alpha inhibits hepatocarcinogenesis through mediating NF-κB signaling pathway
2014
Ischaemic preconditioning lowers hepatic GSH and activates p38 and NFkappaB to promote cell cycle entry via cyclin D1: mechanism of protection against ischemia reperfusion injury in Micea brief period of hepatic ischaemia and reperfusion (preconditioning)
2002